Broadfin Capital’s Cardiovascular Systems, Inc. CSII Stock Holding History

Broadfin Capital’s Portfolio CSII Stock Details CSII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-230,532	Closed	-$5.47M	–	72
2016 Q3	$5.47M	Sell	230,532 -996,969	-81%	-$21.8M	0.49%	50
2016 Q2	$22.6M	Sell	1,227,501 -235,162	-16%	-$3.67M	2.19%	12
2016 Q1	$15.2M	Buy	+1,462,663	New	+$14.8M	1.46%	19
2015 Q4	–	Sell	-1,200,000	Closed	-$19M	–	97
2015 Q3	$19M	Buy	+1,200,000	New	+$30.2M	1.06%	19

Other funds holding CSII

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return

Broadfin Capital's CSII Position: Q4 2016 in Review

Broadfin Capital sold out of Cardiovascular Systems, Inc. (CSII) in Q4 2016, closing a stake of 230,532 shares — an estimated $5.47M sold.

Broadfin Capital first reported a position in CSII in Q3 2015 and held it in 4 quarters. The position peaked at $22.6M in Q2 2016. 142 funds tracked by Wall St. Rank hold CSII as of Q4 2016.

Broadfin Capital reported no remaining Cardiovascular Systems, Inc. position as of Q4 2016 after selling out during the quarter.
Broadfin Capital sold 230,532 Cardiovascular Systems, Inc. shares in Q4 2016, an estimated $5.47M.
Broadfin Capital first reported a position in Cardiovascular Systems, Inc. in Q3 2015 and held it in 4 quarters.
Broadfin Capital's Cardiovascular Systems, Inc. position peaked at $22.6M in Q2 2016.
142 funds tracked by Wall St. Rank held Cardiovascular Systems, Inc. as of Q4 2016.

Based on Broadfin Capital's 13F filing for Q4 2016, filed 14 Feb 2017.